Buried dysplasia and early adenocarcinoma arising in Barrett esophagus after porfimer-photodynamic therapy

American Journal of Surgical Pathology

Volumn 31, Issue 3, 2007, Pages 403-409

  Mino Kenudson, Mari ^a   Ban, Shinichi ^b   Ohana, Masaya ^a,c   Puricelli, William ^a   Deshpande, Vikram ^a   Shimizu, Michio ^b   Nishioka, Norman S ^a   Lauwers, Gregory Y ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c TENRI HOSPITAL   (Japan)

Author keywords

Barrett esophagus; Buried; Carcinoma; Dysplasia; Histopathology; Photodynamic therapy; Porfimer

Indexed keywords

PHOTOFRIN; PROTON PUMP INHIBITOR; RANITIDINE; PHOTOFRIN II; PHOTOSENSITIZING AGENT;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER GRADING; CANCER LOCALIZATION; DRUG HYPERSENSITIVITY; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHOTODYNAMIC THERAPY; PREVALENCE; SQUAMOUS EPITHELIUM; TREATMENT RESPONSE; ADENOCARCINOMA; ESOPHAGUS TUMOR; MIDDLE AGED; PATHOLOGY; PHOTOCHEMOTHERAPY; PRECANCER; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; DIHEMATOPORPHYRIN ETHER; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PRECANCEROUS CONDITIONS;

EID: 34247606577     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000213407.03064.37     Document Type: Article

References (41)

1. Ackroyd R, Brown NJ, Davis MF, et al. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial. Gut. 2000;47:612-617.
2. Ackroyd R, Kelty CJ, Brown NJ, et al. Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up. Endoscopy. 2003;35:496-501.
3. Ban S, Mino M, Nishioka NS, et al. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus. Am J Surg Pathol. 2004;28:1466-1473.
4. Barham CP, Jones RL, Biddlestone LR, et al. Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation. Gut. 1997;41:281-284.
5. Barr H, Shepherd NA, Dix A, et al. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet. 1996;348:584-585.
6. Biddlestone LR, Barham CP, Wilkinson SP, et al. The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy. Am J Surg Pathol. 1998;22:239-245.
7. Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA. 1993;270:1320.
8. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am. 1997;26:487-494.
9. Falk GW. Barrett's esophagus. Gastroenterology. 2002;122:1569-1591.
10. Goldblum JR, Lauwers GY. Dysplasia arising in Barrett's esophagus: diagnostic pitfalls and natural history. Semin Diagn Pathol. 2002;19:12-19.
11. Gossner L. Photodynamic therapy: esophagus. Can J Gastroenterol. 2002;16:642-644.
12. Gossner L, Stolte M, Sroka R, et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology. 1998;114:448-455.
13. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol. 1994;25:982-993.
14. Holscher AH, Bollschweiler E, Schneider PM, et al. Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer. 1995;76:178-186.
15. Krishnadath KK, Wang KK, Taniguchi K, et al. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology. 2000;119:624-630.
16. Mino-Kenudson M, Ohama M, Ban S, et al. Barrett esophagus associated neoplasms treated by photodynamic therapy: determination of limiting factors. Lab Invest. 2006;86(suppl 1):A114.
17. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001;32:368-378.
18. Ohana M, Mino-Kenudson M, Ban S, et al. Frequent persistence of dysplasia by systematic pathological evaluation after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or early adenocarcinoma. Gastroenterology. 2005;128(4, suppl 2):A72.
19. Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc. 1999;49:1-7.
20. Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc. 2003;58:183-188.
21. Overholt BF, Lightdale CJ, Wang KK, et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc. 2005;62:488-498.
22. Panjehpour M, Overholt BF, Haydek JM, et al. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation. Am J Gastroenterol. 2000;95:2177-2184.
23. Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst. 1993;85:443-456.
24. Patti MG, Corvera CU, Glasgow RE, et al. A hospital's annual rate of esophagectomy influences the operative mortality rate. J Gastrointest Surg. 1998;2:186-192.
25. Reed MF, Tolis G Jr, Edil BH, et al. Surgical treatment of esophageal high-grade dysplasia. Ann Thorac Surg. 2005;79:1110-1115; Discussion 1110-1115.
26. Reid BJ, Levine DS, Longton G, et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol. 2000;95:1669-1676.
27. Rice TW, Blackstone EH, Goldblum JR, et al. Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg. 2001;122:1077-1090.
28. Sabik JF, Rice TW, Goldblum JR, et al. Superficial esophageal carcinoma. Ann Thorac Surg. 1995;60:896-901; Discussion 902.
29. Sampliner RE, Fass R. Partial regression of Barrett's esophagus-an inadequate endpoint. Am J Gastroenterol. 1993;88:2092-2094.
30. Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc. 1996;44:532-535.
31. Sharma P. An update on strategies for eradication of Barrett's mucosa. Am J Med. 2001;111(suppl 8A):147S-152S.
32. Sharma P, Morales TG, Bhattacharyya A, et al. Squamous islands in Barrett's esophagus: what lies underneath? Am J Gastroenterol. 1998;93:332-335.
33. Swisher SG, Deford L, Merriman KW, et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2000;119:1126-1132.
34. van Laethem JL, Cremer M, Peny MO, et al. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut. 1998;43:747-751.
35. van Laethem JL, Peny MO, Salmon I, et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut. 2000;46:574-577.
36. Wang KK. Current status of photodynamic therapy of Barrett's esophagus. Gastrointest Endosc. 1999;49:S20-S23.
37. Wang KK. Photodynamic therapy of Barrett's esophagus. Gastrointest Endosc Clin N Am. 2000;10:409-419.
38. Wang KK, Sampliner RE. Mucosal ablation therapy of Barrett esophagus. Mayo Clin Proc. 2001;76:433-437.
39. Wilkinson SP, Biddlestone L, Gore S, et al. Regression of columnarlined (Barrett's) oesophagus with omeprazole 40mg daily: results of 5 years of continuous therapy. Aliment Pharmacol Ther. 1999;13:1205-1209.
40. Wolfsen HC, Woodward TA, Raimondo M. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Mayo Clin Proc. 2002;77:1176-1181.
41. Wolfsen HC, Hemminger LL, Wallace MB, et al. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer. Aliment Pharmacol Ther. 2004;20:1125-1131.